Business · 09/10/2026Updated: 10/15/2026 · 1 min read
Withdrawal of Approval of Abbreviated New Drug Application for Celecoxib Capsules, 50 Milligrams, 100 Milligrams, 200 Milligrams, and 400 Milligrams
Summary
The US FDA is withdrawing approval of Amneal Pharmaceuticals' abbreviated new drug application (ANDA) 208833 for Celecoxib capsules in various strengths.
Original source language: Federal Register — Health and Human ServicesOpen original release →